Apyx Medical Corp (APYX)
1.38
+0.02
(+1.85%)
USD |
NASDAQ |
Jun 25, 16:00
1.38
0.00 (0.00%)
After-Hours: 20:00
Apyx Medical Research and Development Expense (Quarterly): 1.397M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.397M |
| December 31, 2023 | 1.248M |
| September 30, 2023 | 1.276M |
| June 30, 2023 | 1.199M |
| March 31, 2023 | 1.271M |
| December 31, 2022 | 1.255M |
| September 30, 2022 | 1.061M |
| June 30, 2022 | 1.07M |
| March 31, 2022 | 1.158M |
| December 31, 2021 | 0.947M |
| September 30, 2021 | 1.175M |
| June 30, 2021 | 1.084M |
| March 31, 2021 | 1.115M |
| December 31, 2020 | 0.918M |
| September 30, 2020 | 1.047M |
| June 30, 2020 | 0.975M |
| March 31, 2020 | 0.98M |
| December 31, 2019 | 1.097M |
| September 30, 2019 | 1.016M |
| June 30, 2019 | 0.888M |
| March 31, 2019 | 0.73M |
| December 31, 2018 | 0.659M |
| September 30, 2018 | 0.613M |
| June 30, 2018 | 0.763M |
| March 31, 2018 | 0.514M |
| Date | Value |
|---|---|
| December 31, 2017 | 0.341M |
| September 30, 2017 | 0.487M |
| June 30, 2017 | 0.696M |
| March 31, 2017 | 0.709M |
| December 31, 2016 | -0.908M |
| September 30, 2016 | 0.681M |
| June 30, 2016 | 0.592M |
| March 31, 2016 | 0.668M |
| December 31, 2015 | 0.626M |
| September 30, 2015 | 0.583M |
| June 30, 2015 | 0.505M |
| March 31, 2015 | 0.446M |
| December 31, 2014 | 0.397M |
| September 30, 2014 | 0.368M |
| June 30, 2014 | 0.318M |
| March 31, 2014 | 0.332M |
| December 31, 2013 | 0.322M |
| September 30, 2013 | 0.291M |
| June 30, 2013 | 0.314M |
| March 31, 2013 | 0.333M |
| December 31, 2012 | 0.36M |
| September 30, 2012 | 0.322M |
| June 30, 2012 | 0.349M |
| March 31, 2012 | 0.298M |
| December 31, 2011 | 0.273M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.888M
Minimum
Jun 2019
1.397M
Maximum
Mar 2024
1.109M
Average
1.090M
Median
Research and Development Expense (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 7.452M |
| Retractable Technologies Inc | 0.1423M |
| Xtant Medical Holdings Inc | 0.527M |
| Asensus Surgical Inc | 8.091M |
| Catheter Precision Inc | 0.037M |